Intrinsic Value of S&P & Nasdaq Contact Us

Hoth Therapeutics, Inc. HOTH NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Hoth Therapeutics, Inc. (HOTH) has 11 known insider and institutional holders on record. The largest holder is Hayes Anthony with 1,130,674 shares. Other notable holders include Knie Robb and AHERN JAMES P..

Over the last 12 months, insiders have made 3 transactions in HOTH stock — 1 buys (valued at RSU Award) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

HOTH Insider Ownership

Top Holder
Hayes Anthony
1,130,674 shares
Buys (12 mo)
1
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 33%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Hayes Anthony 10 Percent Owner 1,130,674 2020-05-29
100%
2 Knie Robb CEO and President 858,131 2025-08-28
76%
3 Ahern James P. 10 Percent Owner 750,000 2019-03-04
66%
4 Johns Stefanie Chief Scientific Officer 250,000 2022-03-18
22%
5 Springer Graig Director 70,000 2025-01-15
6%
6 Briones David S. Chief Financial Officer 50,000 2019-03-07
4%
7 Mats Vadim Director 33,000 2021-02-01
3%
8 Sarnoff David Director 25,000 2024-08-21
2%
9 Linsley Wayne Director 25,000 2024-08-21
2%
10 Pavell Jeff Director 25,000 2024-08-21
2%
11 Rice Kenneth L Jr Director 15,000 2020-07-23
1%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2025-08-28 Knie Robb CEO and President Tax Withholding of RSU 310,744 $1.21 $376K
2025-08-27 Knie Robb CEO and President RSU Award 800,000 - -
2025-05-08 Camarra Christopher Michael Director Unknown - - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message